Clinical Investigations – Research Article

Sicińska J.a,b,c· Kasprzak M.b· Walecka I.a

Author affiliations

aDepartment of Dermatology, CSK MSWiA/CMKP, Warsaw, Poland
bTrichoLAB, Warsaw, Poland
cDermiq Medical Center, Warsaw, Poland

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: October 07, 2021
Accepted: February 09, 2022
Published online: May 19, 2022

Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 0

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Abstract

Introduction: Frontal fibrosing alopecia (FFA) is a relatively recently described scarring hair loss condition. Frontal hair recession is observed in a vast majority of patients; other scalp areas may be included. Assessment of hair loss progression in FFA remains challenging mainly due to difficulties in unambiguous determination of the hairline. Various patterns of scarring and subtle progression rate are among factors which make naked-eye observations of limited use. Methods: Trichoscopy of the frontal hairline with hair-to-hair matching was conducted in patients with FFA patients with disease progression and clinically stable hairline. Hair loss was assessed based on analysis of trichoscopy-derived follicular maps. A relative hair density loss was calculated, and the hairline recession equivalent (HRE) was proposed as a novel hair loss progression measure. Results: Two patterns of hair loss were observed: one with significant decrease of hair density within a width of 1 mm and one with diffuse loss within a width of 10 mm. Conclusion: The hair density profile may be a useful tool to characterize different disease progression patterns. The HRE is potentially a very accurate and sensitive parameter to quantify local hair loss progression in FFA.

© 2022 S. Karger AG, Basel

References Mirmirani P, Tosti A, Goldberg L, Whiting D, Sotoodian B. Frontal fibrosing alopecia: an emerging epidemic. Skin Appendage Disord. 2019;5(2):90–3. Heppt MV, Letulé V, Laniauskaite I, Reinholz M, Tietze JK, Wolff H, et al. Frontal fibrosing alopecia: a retrospective analysis of 72 patients from a German academic center. Facial Plast Surg. 2018 Feb;34(1):88–94. Banka N, Mubki T, Bunagan MJ, McElwee K, Shapiro J. Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up. Int J Dermatol. 2014;53(11):1324–30. Lin J, Valdebran M, Bergfeld W, Conic RZ, Piliang M, Atanaskova Mesinkovska N. Hypopigmentation in frontal fibrosing alopecia. J Am Acad Dermatol. 2017;76(6):1184–6. McSweeney SM, Christou EAA, Dand N, Boalch A, Holmes S, Harries M, et al. Frontal fibrosing alopecia: a descriptive cross-sectional study of 711 cases in female patients from the UK. Br J Dermatol. 2020 Dec;183(6):1136–8. Starace M, Brandi N, Alessandrini A, Bruni F, Piraccini BM. Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre. J Eur Acad Dermatol Venereol. 2019 Feb;33(2):433–8. Donovan JC. Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia. JAAD Case Rep. 2015;1(6):353–5. Pincelli TP, Heckman MG, Cochuyt JJ, Sluzevich JC. Valchlor® in the treatment of lichen planopilaris and frontal fibrosing alopecia: a single arm, open-label, exploratory study. Int J Trichology. 2020 Sep–Oct;12(5):220–6. Katoulis A, Georgala S, Bozi E, Papadavid E, Kalogeromitros D, Stavrianeas N. Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus. J Eur Acad Dermatol Venereol. 2009;23(5):580–2. Rakowska A, Gradzińska A, Olszewska M, Rudnicka L. Efficacy of isotretinoin and acitretin in treatment of frontal fibrosing alopecia: retrospective analysis of 54 cases. J Drugs Dermatol. 2017 Oct 1;16(10):988–92. Moreno-Arrones OM, Saceda-Corralo D, Fonda-Pascual P, Rodrigues-Barata AR, Buendía-Castaño D, Alegre-Sánchez A, et al. Frontal fibrosing alopecia: clinical and prognostic classification. J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1739–45. Vañó-Galván S, Molina-Ruiz AM, Serrano-Falcón C, Arias-Santiago S, Rodrigues-Barata AR, Garnacho-Saucedo G, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014 Apr;70(4):670–8. Ramos PM, Anzai A, Duque-Estrada B, Farias DC, Melo DF, Mulinari-Brenner F, et al. Regarding methodological concerns in clinical studies on frontal fibrosing alopecia. J Am Acad Dermatol. 2021 Apr;84(4):e207–8. Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, Cucchía J, Dlova NC, Gavazzoni Dias MFR, et al. Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disord. 2019 Aug;5(5):309–15. Pirmez R, Duque-Estrada B, Abraham LS, Pinto GM, de Farias DC, Kelly Y, et al. It’s not all traction: the pseudo “fringe sign” in frontal fibrosing alopecia. Br J Dermatol. 2015 Nov;173(5):1336–8. Rossi A, Grassi S, Fortuna MC, Garelli V, Pranteda G, Caro G, et al. Unusual patterns of presentation of frontal fibrosing alopecia: a clinical and trichoscopic analysis of 98 patients. J Am Acad Dermatol. 2017 Jul;77(1):172–4. Lis-Święty A, Brzezińska-Wcisło L. Frontal fibrosing alopecia: a disease that remains enigmatic. Postepy Dermatol Alergol. 2020 Aug;37(4):482–9. Holmes S, Ryan T, Young D, Harries M; British Hair and Nail Society. Frontal fibrosing alopecia severity index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia. Br J Dermatol. 2016 Jul;175(1):203–7. Saceda-Corralo D, Moreno-Arrones ÓM, Fonda-Pascual P, Pindado-Ortega C, Buendía-Castaño D, Alegre-Sánchez A, et al. Development and validation of the frontal fibrosing alopecia severity score. J Am Acad Dermatol. 2018 Mar;78(3):522–9. Inui S, Nakajima T, Shono F, Itami S. Dermoscopic findings in frontal fibrosing alopecia: report of four cases. Int J Dermatol. 2008 Aug;47(8):796–9. Tosti A, Miteva M, Torres F. Lonely hair: a clue to the diagnosis of frontal fibrosing alopecia. Arch Dermatol. 2011;147(10):1240. Martínez-Velasco MA, Vázquez-Herrera NE, Misciali C, Vincenzi C, Maddy AJ, Asz-Sigall D, et al. Frontal fibrosing alopecia severity index: a trichoscopic visual scale that correlates thickness of peripilar casts with severity of inflammatory changes at pathology. Skin Appendage Disord. 2018 Oct;4(4):277–80. Dlova NC, Dadzie OE. Frontal fibrosing alopecia severity index (FFASI): a call for a more inclusive and globally relevant severity index for frontal fibrosing alopecia. Br J Dermatol. 2017 Sep;177(3):883–4. Holmes S, Harries M. Response to “Development and validation of the frontal fibrosing alopecia severity score”. J Am Acad Dermatol. 2018 Dec;79(6):e115–6. Saceda-Corralo D, Moreno-Arrones ÓM, Pindado-Ortega C, Vañó-Galván S. Reply to: “Response to ‘Development and validation of the frontal fibrosing alopecia severity score’”. J Am Acad Dermatol. 2018 Dec;79(6):e117. Kasprzak M, Sicińska J, Tosti A. Follicular map: a novel approach to quantitative trichoscopy. Skin Appendage Disord. 2019 Jun;5(4):216–20. Grimalt R, Kasprzak M, Sicinska J, Rocha MF, Tosti A. Efficiency of hair detection in hair to hair matched trichoscopy – world congress for hair research. Sitges/Barcelona. 2019 Apr. Article / Publication Details

First-Page Preview

Received: October 07, 2021
Accepted: February 09, 2022
Published online: May 19, 2022

Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 0

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.